These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 467354)

  • 21. Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis.
    Malluche HH; Faugere MC; Fanti P; Price PA
    Kidney Int; 1984 Dec; 26(6):869-74. PubMed ID: 6335905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging of bone in the diagnostics of renal osteodystrophy in children with chronic renal failure.
    Ziółkowska H; Pańczyk-Tomaszewska M; Majkowska Z; Rajkowski T; Debiński A; Przedlacki J; Sawicki A; Ostrowski K; Marciński A; Roszkowska-Blaim M
    Med Sci Monit; 2001; 7(5):1034-42. PubMed ID: 11535955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone aluminum and histomorphometric features of renal osteodystrophy.
    Hodsman AB; Sherrard DJ; Alfrey AC; Ott S; Brickman AS; Miller NL; Maloney NA; Coburn JW
    J Clin Endocrinol Metab; 1982 Mar; 54(3):539-46. PubMed ID: 7056841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone histomorphometry in hemodialysed patients.
    de Vernejoul MC; Kuntz D; Miravet L; Gueris J; Bielakoff J; Ryckewaert A
    Metab Bone Dis Relat Res; 1981; 3(3):175-9. PubMed ID: 7347793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of 1,25(OH)2-vitamin D3 to separate 'types' on renal osteodystrophy.
    Coburn JW; Brickman AS; Sherrard DJ; Singer FR; Wong EG; Baylink DJ; Norman AW
    Proc Eur Dial Transplant Assoc; 1977; 14():442-50. PubMed ID: 600961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.
    Andress DL; Norris KC; Coburn JW; Slatopolsky EA; Sherrard DJ
    N Engl J Med; 1989 Aug; 321(5):274-9. PubMed ID: 2631697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parathyroid gland responsiveness to acute hypocalcemia in dialysis osteomalacia.
    Kraut JA; Shinaberger JH; Singer FR; Sherrard DJ; Saxton J; Miller JH; Kurokawa K; Coburn JW
    Kidney Int; 1983 May; 23(5):725-30. PubMed ID: 6876568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A pathological analysis of 51 cases of renal osteodystrophy].
    Yu YF; Hu YX; Zhu P
    Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):448-50. PubMed ID: 8275821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia.
    Andress D; Felsenfeld AJ; Voigts A; Llach F
    Kidney Int; 1983 Sep; 24(3):364-70. PubMed ID: 6645210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum immunoreactive parathyroid hormone and 25-hydroxyvitamin D in patients with uremic bone diseases.
    Shen F-H ; Baylink DJ; Sherrard DJ; Shen L; Maloney NA; Wergedal JE
    J Clin Endocrinol Metab; 1975 Jun; 40(6):1009-17. PubMed ID: 1133150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology.
    Fletcher S; Jones RG; Rayner HC; Harnden P; Hordon LD; Aaron JE; Oldroyd B; Brownjohn AM; Turney JH; Smith MA
    Nephron; 1997; 75(4):412-9. PubMed ID: 9127327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal osteodystrophy in end-stage renal failure.
    Nortman DF; Coburn JW
    Postgrad Med; 1978 Nov; 64(5):123-30. PubMed ID: 714829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium and phosphorus metabolism in chronic uremia.
    Fiaschi E; Mioni G; Maschio G; D'Angelo A; Ossi E
    Nephron; 1975; 14(2):163-80. PubMed ID: 1093055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated bone aluminum and suppressed parathyroid hormone levels in hypercalcemic dialysis patients.
    Piraino B; Chen T; Puschett JB
    Am J Nephrol; 1989; 9(3):190-7. PubMed ID: 2757078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal osteodystrophy in children on maintenance haemodialysis.
    Mehls O; Krempien B; Ritz E; Schärer K; Schüler HW
    Proc Eur Dial Transplant Assoc; 1973; 10(0):197-201. PubMed ID: 4802577
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies on the pathogenesis and pathophysiology of renal osteodystrophy. II. Bone histology of chronic renal failure patients at the time of starting hemodialysis].
    Sato T
    Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1145-58. PubMed ID: 7815747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal osteodystrophy in early chronic renal failure.
    Suzuki M; Hirasawa Y
    Contrib Nephrol; 1980; 22():28-38. PubMed ID: 7398337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term effects of a combination of 25-hydroxycholecalciferol and 1-alpha-hydroxycholecalciferol on osteodystrophy in chronic hemodialysis patients].
    Sebert JL; Marie A; Kuntz D; Marie P; Gueris J; Smadja A; Fournier A; Quichaud J
    Rev Rhum Mal Osteoartic; 1981; 48(7-9):535-41. PubMed ID: 7291931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy.
    Lafage MH; Combe C; Fournier A; Aparicio M
    Kidney Int; 1992 Nov; 42(5):1217-25. PubMed ID: 1453606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.